888 reiterated their reiterates rating on shares of Amdocs ( NASDAQ:DOX – Get Rating ) in a research note released on Thursday, Benzinga reports. A number of other research firms have also recently issued reports on DOX. Oppenheimer increased their target price on Amdocs from $94.00 to $99.00 and gave the stock an outperform rating in a research note on Wednesday, February 1st. StockNews.com began coverage on Amdocs in a research note on Thursday, March 16th. They set a buy rating for the company.
https://www.dailypolitical.com/2023/05/15/amdocs-nasdaqdox-rating-reiterated-by-888.html#dailypolitical
You must login before you can post a comment.